TXNDC5 and gastric cancer: A study has found that there is an interaction between PRDX4 and TXNDC5 protein molecules in gastric cancer, and PRDX4 may reduce lymphocyte infiltration, affect the expression of multiple immune checkpoints, leading to anti-tumor immune suppression (37).